FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045735600> ?p ?o ?g. }

• W2045735600 endingPage "158" @default.
• W2045735600 startingPage "150" @default.
• W2045735600 abstract "Cilostazol, an inhibitor of phosphodiesterase type III, is an antiplatelet agent and vasodilator. Some clinical reports have suggested that this drug can improve progressive and refractory lymphedema.In this study, we investigated whether cilostazol has the potential to proliferate lymphatic vessels and to improve lymphatic function using human lymphatic endothelial cells (LECs) and mouse lymphedema models.Human LECs were counted at several time points while they were cultured in the presence of cilostazol and/or protein kinase A inhibitor. After receiving a diet including 0.1% cilostazol or control diet, skin tissue and lymphatic function of k-cyclin transgenic (kCYC(+/-)) mice, which have pernicious lymphatic dysfunction, was analyzed. A different lymphedema model was generated in wild type mice by excising circumferential tail skin to remove the superficial lymphatics. After oral administration of cilostazol, tail lymphedema was examined in this mouse model.Proliferation of LECs was promoted in a dose-dependent manner, which was partially inhibited by a protein kinase A inhibitor. Lymphatic vessel count increased in the cilostazol-treated kCYC(+/-) mice over that in the non-treated mice. Lymph flow improved in cilostazol-fed kCYC(+/-) mice as assessed by subcutaneous injection of Evans blue dye into the footpad. Oral administration of cilostazol also decreased lymphedema in a tail of wild type mice.Cilostazol promoted growth of human LECs and improved lymph flow and lymphedema in two different mouse lymphedema models. These results suggest that cilostazol would be a promising agent for the treatment of lymphedema." @default.
• W2045735600 created "2016-06-24" @default.
• W2045735600 creator A5033228282 @default.
• W2045735600 creator A5048070309 @default.
• W2045735600 creator A5055921747 @default.
• W2045735600 creator A5067689004 @default.
• W2045735600 creator A5070275625 @default.
• W2045735600 creator A5079579851 @default.
• W2045735600 creator A5081072346 @default.
• W2045735600 creator A5091333853 @default.
• W2045735600 date "2014-05-01" @default.
• W2045735600 modified "2023-10-16" @default.
• W2045735600 title "Cilostazol improves lymphatic function by inducing proliferation and stabilization of lymphatic endothelial cells" @default.
• W2045735600 cites W100844413 @default.
• W2045735600 cites W1966268314 @default.
• W2045735600 cites W1981268098 @default.
• W2045735600 cites W1991298929 @default.
• W2045735600 cites W1992101966 @default.
• W2045735600 cites W1992398878 @default.
• W2045735600 cites W2004566300 @default.
• W2045735600 cites W2012482383 @default.
• W2045735600 cites W2035301328 @default.
• W2045735600 cites W2037453625 @default.
• W2045735600 cites W2062608332 @default.
• W2045735600 cites W2113215822 @default.
• W2045735600 cites W2113972274 @default.
• W2045735600 cites W2118462346 @default.
• W2045735600 cites W2129133722 @default.
• W2045735600 cites W2140161831 @default.
• W2045735600 cites W2146553975 @default.
• W2045735600 cites W2155591311 @default.
• W2045735600 cites W2158659385 @default.
• W2045735600 cites W4297704090 @default.
• W2045735600 doi "https://doi.org/10.1016/j.jdermsci.2014.01.001" @default.
• W2045735600 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24517869" @default.
• W2045735600 hasPublicationYear "2014" @default.
• W2045735600 type Work @default.
• W2045735600 sameAs 2045735600 @default.
• W2045735600 citedByCount "19" @default.
• W2045735600 countsByYear W20457356002014 @default.
• W2045735600 countsByYear W20457356002015 @default.
• W2045735600 countsByYear W20457356002017 @default.
• W2045735600 countsByYear W20457356002019 @default.
• W2045735600 countsByYear W20457356002020 @default.
• W2045735600 countsByYear W20457356002021 @default.
• W2045735600 countsByYear W20457356002022 @default.
• W2045735600 countsByYear W20457356002023 @default.
• W2045735600 crossrefType "journal-article" @default.
• W2045735600 hasAuthorship W2045735600A5033228282 @default.
• W2045735600 hasAuthorship W2045735600A5048070309 @default.
• W2045735600 hasAuthorship W2045735600A5055921747 @default.
• W2045735600 hasAuthorship W2045735600A5067689004 @default.
• W2045735600 hasAuthorship W2045735600A5070275625 @default.
• W2045735600 hasAuthorship W2045735600A5079579851 @default.
• W2045735600 hasAuthorship W2045735600A5081072346 @default.
• W2045735600 hasAuthorship W2045735600A5091333853 @default.
• W2045735600 hasConcept C120770815 @default.
• W2045735600 hasConcept C121608353 @default.
• W2045735600 hasConcept C126322002 @default.
• W2045735600 hasConcept C134018914 @default.
• W2045735600 hasConcept C181152851 @default.
• W2045735600 hasConcept C203014093 @default.
• W2045735600 hasConcept C2776636583 @default.
• W2045735600 hasConcept C2777628954 @default.
• W2045735600 hasConcept C2779013556 @default.
• W2045735600 hasConcept C2779820409 @default.
• W2045735600 hasConcept C2781392513 @default.
• W2045735600 hasConcept C2910366181 @default.
• W2045735600 hasConcept C530470458 @default.
• W2045735600 hasConcept C71924100 @default.
• W2045735600 hasConcept C98274493 @default.
• W2045735600 hasConceptScore W2045735600C120770815 @default.
• W2045735600 hasConceptScore W2045735600C121608353 @default.
• W2045735600 hasConceptScore W2045735600C126322002 @default.
• W2045735600 hasConceptScore W2045735600C134018914 @default.
• W2045735600 hasConceptScore W2045735600C181152851 @default.
• W2045735600 hasConceptScore W2045735600C203014093 @default.
• W2045735600 hasConceptScore W2045735600C2776636583 @default.
• W2045735600 hasConceptScore W2045735600C2777628954 @default.
• W2045735600 hasConceptScore W2045735600C2779013556 @default.
• W2045735600 hasConceptScore W2045735600C2779820409 @default.
• W2045735600 hasConceptScore W2045735600C2781392513 @default.
• W2045735600 hasConceptScore W2045735600C2910366181 @default.
• W2045735600 hasConceptScore W2045735600C530470458 @default.
• W2045735600 hasConceptScore W2045735600C71924100 @default.
• W2045735600 hasConceptScore W2045735600C98274493 @default.
• W2045735600 hasIssue "2" @default.
• W2045735600 hasLocation W20457356001 @default.
• W2045735600 hasLocation W20457356002 @default.
• W2045735600 hasOpenAccess W2045735600 @default.
• W2045735600 hasPrimaryLocation W20457356001 @default.
• W2045735600 hasRelatedWork W1983535697 @default.
• W2045735600 hasRelatedWork W2001658518 @default.
• W2045735600 hasRelatedWork W2045735600 @default.
• W2045735600 hasRelatedWork W2049291306 @default.
• W2045735600 hasRelatedWork W2062646801 @default.
• W2045735600 hasRelatedWork W2075340543 @default.
• W2045735600 hasRelatedWork W2076523281 @default.

• next